TipRanks
China Resources Pharmaceutical Group Ltd. (HK:3320)
:3320
Hong Kong Market
3320
China Resources Pharmaceutical Group Ltd.
RESEARCH TOOLSreports
Want to see HK:3320 full AI Analyst Report?

China Resources Pharmaceutical Group Ltd. (3320) Ratios

4 Followers

China Resources Pharmaceutical Group Ltd. Ratios

HK:3320's free cash flow for Q2 2026 was ¥0.16. For the 2026 fiscal year, HK:3320's free cash flow was decreased by ¥ and operating cash flow was ¥0.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.43 1.42 1.41 1.33 1.25
Quick Ratio
 1.12 1.11 1.13 1.09 1.03
Cash Ratio
 0.19 0.11 0.12 0.18 0.18
Solvency Ratio
 0.05 0.05 0.04 0.04 0.04
Operating Cash Flow Ratio
 0.12 0.14 0.12 0.12 0.08
Short-Term Operating Cash Flow Coverage
 0.24 0.28 0.37 0.34 0.21
Net Current Asset Value
¥ 40.26BHK$ 37.15BHK$ 27.85BHK$ 9.37B¥ 20.22B
Leverage Ratios
Debt-to-Assets Ratio
 0.34 0.33 0.27 0.23 0.26
Debt-to-Equity Ratio
 1.87 1.83 1.43 1.23 1.29
Debt-to-Capital Ratio
 0.65 0.65 0.59 0.55 0.56
Long-Term Debt-to-Capital Ratio
 0.31 0.29 0.32 0.23 0.17
Financial Leverage Ratio
 5.57 5.56 5.34 5.37 4.92
Debt Service Coverage Ratio
 0.17 0.20 0.26 0.28 0.24
Interest Coverage Ratio
 5.99 6.33 5.65 4.88 3.79
Debt to Market Cap
 4.12 3.72 2.01 1.89 1.57
Interest Debt Per Share
 18.52 17.04 12.05 10.27 10.62
Net Debt to EBITDA
 4.60 4.70 3.62 2.43 2.57
Profitability Margins
Gross Profit Margin
16.36%16.51%15.79%15.60%15.40%
EBIT Margin
4.29%4.69%4.65%4.54%4.85%
EBITDA Margin
5.86%6.18%5.64%5.71%6.09%
Operating Profit Margin
4.21%4.63%4.70%4.31%4.26%
Pretax Profit Margin
4.35%4.38%4.24%4.02%3.88%
Net Profit Margin
1.53%1.50%1.30%1.43%1.38%
Continuous Operations Profit Margin
3.54%3.58%3.26%3.16%3.09%
Net Income Per EBT
35.12%34.30%30.66%35.46%35.52%
EBT Per EBIT
103.38%94.43%90.17%93.25%91.15%
Return on Assets (ROA)
1.38%1.41%1.30%1.42%1.43%
Return on Equity (ROE)
7.92%7.86%6.95%7.62%7.06%
Return on Capital Employed (ROCE)
7.57%8.69%9.66%8.49%10.05%
Return on Invested Capital (ROIC)
4.08%4.73%5.45%5.68%5.46%
Return on Tangible Assets
1.57%1.62%1.47%1.59%1.84%
Earnings Yield
17.02%16.10%9.96%11.96%8.82%
Efficiency Ratios
Receivables Turnover
 2.16 2.65 2.53 3.27 2.48
Payables Turnover
 4.87 5.25 5.42 4.17 4.41
Inventory Turnover
 4.92 5.20 5.86 7.12 7.23
Fixed Asset Turnover
 8.17 8.31 10.41 9.68 10.27
Asset Turnover
 0.90 0.94 1.00 1.00 1.04
Working Capital Turnover Ratio
 4.41 4.87 5.41 6.89 7.32
Cash Conversion Cycle
 168.07 138.47 138.95 75.19 115.15
Days of Sales Outstanding
 168.82 137.76 144.02 111.48 147.40
Days of Inventory Outstanding
 74.16 70.23 62.33 51.25 50.46
Days of Payables Outstanding
 74.91 69.52 67.40 87.54 82.71
Operating Cycle
 242.98 207.99 206.35 162.73 197.86
Cash Flow Ratios
Operating Cash Flow Per Share
 3.34 3.63 2.79 2.48 1.73
Free Cash Flow Per Share
 2.87 3.00 2.32 1.98 1.20
CapEx Per Share
 0.47 0.63 0.48 0.50 0.53
Free Cash Flow to Operating Cash Flow
 0.86 0.83 0.83 0.80 0.69
Dividend Paid and CapEx Coverage Ratio
 5.48 4.73 3.80 3.79 2.54
Capital Expenditure Coverage Ratio
 7.09 5.77 5.85 4.96 3.25
Operating Cash Flow Coverage Ratio
 0.18 0.22 0.24 0.25 0.17
Operating Cash Flow to Sales Ratio
 0.07 0.08 0.06 0.06 0.04
Free Cash Flow Yield
65.46%67.36%40.62%38.53%19.00%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 5.84 6.18 10.04 8.36 11.34
Price-to-Sales (P/S) Ratio
 0.09 0.09 0.13 0.12 0.16
Price-to-Book (P/B) Ratio
 0.45 0.49 0.70 0.64 0.80
Price-to-Free Cash Flow (P/FCF) Ratio
 1.53 1.48 2.46 2.60 5.26
Price-to-Operating Cash Flow Ratio
 1.31 1.23 2.04 2.07 3.64
Price-to-Earnings Growth (PEG) Ratio
 0.10 0.22 -0.57 2.76 1.13
Enterprise Value Multiple
 6.13 6.21 5.94 4.52 5.13
Enterprise Value
 110.24B 115.20B 91.76B 69.74B 79.44B
EV to EBITDA
 6.13 6.21 5.94 4.52 5.13
EV to Sales
 0.36 0.38 0.33 0.26 0.31
EV to Free Cash Flow
 6.12 6.12 6.31 5.62 10.53
EV to Operating Cash Flow
 5.26 5.06 5.23 4.48 7.29
Tangible Book Value Per Share
 15.44 14.52 11.69 11.59 6.29
Shareholders’ Equity Per Share
 9.71 9.11 8.17 8.05 7.89
Tax and Other Ratios
Effective Tax Rate
 0.19 0.18 0.23 0.19 0.20
Revenue Per Share
 48.79 47.75 43.64 43.04 40.45
Net Income Per Share
 0.75 0.72 0.57 0.61 0.56
Tax Burden
 0.35 0.34 0.31 0.35 0.36
Interest Burden
 1.01 0.93 0.91 0.89 0.80
Research & Development to Revenue
 0.01 0.01 <0.01 0.01 <0.01
SG&A to Revenue
 0.11 0.11 0.10 0.03 0.02
Stock-Based Compensation to Revenue
 >-0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.60 1.74 4.83 1.57 2.63